Mutations in the GTPCH1 gene (GCH1) are associated with malignant phenylketonuria and hyperphenylalaninemia, as well as L-DOPA (Levodopa)-responsive dystonia [7]–[9]. The gene discussed is GCH1; the disease is phenylketonuria.